ORTHOCELL LIMITED - Announcements

0.41%

$1.23

Market Cap $301.1M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

OCC	Orthocell Granted Canadian Tendon Regeneration Patent	PRICE SENSITIVE	31/01/18	284.66KB	Share
OCC	Change in substantial holding MHZ		30/01/18	1.08MB	Share
OCC	Change in substantial holding PA		19/01/18	48.29KB	Share
OCC	Change in substantial holding SRV		19/01/18	735.39KB	Share
OCC	Change in substantial holding MC		19/01/18	46.86KB	Share
OCC	Change in substantial holding QXZ		19/01/18	134.34KB	Share
OCC	New Patent for Suture-Less Repair of Soft Tissue Secured	PRICE SENSITIVE	18/01/18	202.42KB	Share
OCC	Successful Completion of Share Purchase Plan		12/01/18	142.64KB	Share
OCC	Appendix 3B		12/01/18	152.97KB	Share
OCC	Orthocell featured at Biotech Showcase in San Francisco		09/01/18	1.73MB	Share
OCC	50% Patient Treatment Milestone in Human Nerve Trial	PRICE SENSITIVE	02/01/18	198.74KB	Share
OCC	Share Purchase Plan Closing Date Extended		28/12/17	111.04KB	Share
OCC	Appendix 3B and Notice Under Section 708A		20/12/17	157.61KB	Share
OCC	Invitation to Participate in Share Purchase Plan		15/12/17	201.69KB	Share
OCC	Notice Under ASIC Class Order CO 09/425		15/12/17	111.07KB	Share
OCC	Orthocell Granted European Tendon Regeneration Patent	PRICE SENSITIVE	15/12/17	142.65KB	Share
OCC	Orthocell Featured in CommSec Executive Series Interview		14/12/17	387.54KB	Share
OCC	Placement and Share Purchase Plan	PRICE SENSITIVE	13/12/17	568.26KB	Share
OCC	Trading Halt	PRICE SENSITIVE	11/12/17	356.15KB	Share
OCC	Ortho-ATI Case Study Publication	PRICE SENSITIVE	08/12/17	145.58KB	Share
OCC	Orthocell Commences Treatment of its 1,000th Patient		07/12/17	164.85KB	Share
OCC	Orthocell Granted European Cartilage Regeneration Patent	PRICE SENSITIVE	01/12/17	117.55KB	Share
OCC	*Change of Director's Interest Notice - options expiry 5**		30/11/17	395.15KB	Share
OCC	FDA Comprehensive Regenerative Medicine Policy Framework		27/11/17	163.71KB	Share
OCC	Company Update Presentation		21/11/17	2MB	Share
OCC	Results of Meeting		15/11/17	105.8KB	Share
OCC	Orthocell Receives CE Mark for CelGro	PRICE SENSITIVE	09/11/17	214.17KB	Share
OCC	Trading Halt	PRICE SENSITIVE	08/11/17	337.57KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	157.57KB	Share
OCC	Orthocell receives R&D tax incentive refund	PRICE SENSITIVE	24/10/17	126.1KB	Share
OCC	Company Update Presentation		17/10/17	2.05MB	Share
OCC	Orthocell Granted CelGro Patent Protection in Canada	PRICE SENSITIVE	16/10/17	111.48KB	Share
OCC	Notice of Annual General Meeting/Proxy Form	PRICE SENSITIVE	13/10/17	1.01MB	Share
OCC	Surgical Specialties Appointed as Exclusive Distributor	PRICE SENSITIVE	11/10/17	111.15KB	Share
OCC	Orthocell Receives New Patent for Celgro Platform Technology	PRICE SENSITIVE	21/09/17	137.56KB	Share
OCC	Appendix 4G		14/09/17	209.39KB	Share
OCC	Annual Report to shareholders		14/09/17	5.77MB	Share
OCC	Celgro Positive Safety and Performance in Human Hip Study	PRICE SENSITIVE	06/09/17	110.52KB	Share
OCC	1st Patient Recruited in Ortho-ATI Shoulder Tendon Study	PRICE SENSITIVE	05/09/17	270.38KB	Share
OCC	Preliminary Final Report	PRICE SENSITIVE	31/08/17	141.37KB	Share
OCC	Change of Director's Interest Notice SW		08/08/17	28.46KB	Share
OCC	Change of Director's Interest Notice PA		08/08/17	26.97KB	Share
OCC	Change of Director's Interest Notice MC		08/08/17	26.67KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	152.98KB	Share
OCC	Change of Director's Interest Notice PA		25/07/17	27.74KB	Share
OCC	Change of Director's Interest Notice MC		24/07/17	28.2KB	Share
OCC	Change of Director's Interest Notice SW		24/07/17	28.04KB	Share
OCC	Appendix 3B		20/06/17	153.27KB	Share
OCC	Ortho-ACI on Australian Register of Therapeutic Goods	PRICE SENSITIVE	30/05/17	393.81KB	Share
OCC	Ethics Approval Received for Pilot Ortho-ATI Tendon Study	PRICE SENSITIVE	01/05/17	395.89KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	198.16KB	Share
OCC	Response to ASX Query	PRICE SENSITIVE	11/04/17	292.39KB	Share
OCC	Response to ASX Price and Volume Query		10/04/17	292.96KB	Share
OCC	Singapore Patent for CelGro SMART Graft Received	PRICE SENSITIVE	28/03/17	399.32KB	Share
OCC	Appendix 3B		22/03/17	806.38KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/17	692KB	Share
OCC	Orthocell Announces Gluteal Tendon Publication	PRICE SENSITIVE	27/02/17	392.76KB	Share
OCC	Investor Presentation Hong Kong		27/02/17	3.81MB	Share
OCC	Initial Results Positive for CelGro Human Nerve Regeneration	PRICE SENSITIVE	22/02/17	397.25KB	Share
OCC	Orthocell Submits US Regulatory Application for CelGro		08/02/17	400.65KB	Share
OCC	Orthocell Submits US Regulatory Application for CelGro	PRICE SENSITIVE	08/02/17	401.15KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	147.09KB	Share
OCC	Orthocell Cell Factory Patent Granted in Europe	PRICE SENSITIVE	31/01/17	401.51KB	Share
OCC	Orthocell Announces Collaboration with Johnson & Johnson	PRICE SENSITIVE	12/01/17	384.02KB	Share
OCC	Trading Halt	PRICE SENSITIVE	11/01/17	409.26KB	Share
OCC	Orthocell receives R&D tax incentive refund	PRICE SENSITIVE	09/01/17	122.97KB	Share
OCC	Ceasing to be a substantial holder		16/12/16	109.27KB	Share
OCC	Ceasing to be a substantial holder		15/12/16	108.16KB	Share
OCC	Placement Completed		13/12/16	385.51KB	Share
OCC	Appendix 3B		13/12/16	823.48KB	Share
OCC	Change of Share Registry Address		09/12/16	208.53KB	Share
OCC	Orthocell Announces $4 million Capital Raising	PRICE SENSITIVE	07/12/16	391.36KB	Share
OCC	Trading Halt	PRICE SENSITIVE	02/12/16	190.09KB	Share
OCC	Change of Director's Interest Notice PA		02/12/16	307.48KB	Share
OCC	Investor Presentation		02/12/16	1.6MB	Share
OCC	Appendix 3B		28/11/16	123.96KB	Share
OCC	Results of Meeting		28/11/16	381.58KB	Share
OCC	Appendix 4C - quarterly-OCC.AX	PRICE SENSITIVE	31/10/16	290.26KB	Share
OCC	WA Innovation Excellence Award for CelGro Received-OCC.AX		31/10/16	282.46KB	Share
OCC	Orthocell Announces Growth Factor - Cell factory Publication-OCC.AX	PRICE SENSITIVE	31/10/16	280.7KB	Share
OCC	Appendix 4G-OCC.AX		26/10/16	217.93KB	Share
OCC	Annual Report to shareholders-OCC.AX		26/10/16	5.07MB	Share
OCC	Notice of Annual General Meeting/Proxy Form-OCC.AX		26/10/16	1.44MB	Share
OCC	Approval for CelGro Human Nerve Regeneration Study Received-OCC.AX	PRICE SENSITIVE	18/10/16	281.96KB	Share
OCC	Appendix 3B-OCC.AX		14/10/16	804KB	Share
OCC	Investor Presentation CelGro-OCC.AX		19/09/16	12.02MB	Share
OCC	Research Report-OCC.AX		14/09/16	366.87KB	Share
OCC	Full Year Statutory Accounts-OCC.AX		12/09/16	1.19MB	Share
OCC	Amended Change of Director's Interest Notice MC-OCC.AX		12/09/16	311.69KB	Share
OCC	Preliminary Final Report-OCC.AX	PRICE SENSITIVE	31/08/16	533.05KB	Share
OCC	Release of Securities from Escrow-OCC.AX		02/08/16	213.15KB	Share
OCC	Appendix 4C - quarterly-OCC.AX	PRICE SENSITIVE	29/07/16	597.03KB	Share
OCC	Ethics Approval for Pivotal Ortho ATI Tendon Study Received-OCC.AX	PRICE SENSITIVE	12/07/16	383.16KB	Share
OCC	Change of Director's Interest Notice SW-OCC.AX		01/07/16	225.08KB	Share
OCC	United States Tendon Stem Cell and Scaffold Patent Obtained-OCC.AX	PRICE SENSITIVE	21/06/16	383.31KB	Share
OCC	Chinese Patent Received Covering Celgro SMART Graft-OCC.AX	PRICE SENSITIVE	17/06/16	226.76KB	Share
OCC	Early Positive Results for CelGro in Human Tendon Study-OCC.AX	PRICE SENSITIVE	16/06/16	373.13KB	Share
OCC	Orthocell Receives Approval for Human Hip Study Using Celgro-OCC.AX	PRICE SENSITIVE	04/05/16	385.63KB	Share
OCC	Orthocell receives R&D tax incentive refund-OCC.AX	PRICE SENSITIVE	02/05/16	376.67KB	Share
OCC	Appendix 4C - quarterly-OCC.AX	PRICE SENSITIVE	29/04/16	167.82KB	Share

OCC Orthocell Granted Canadian Tendon Regeneration Patent
31/01/18	PRICE SENSITIVE	284.66KB	Share
OCC Change in substantial holding MHZ
30/01/18		1.08MB	Share
OCC Change in substantial holding PA
19/01/18		48.29KB	Share
OCC Change in substantial holding SRV
19/01/18		735.39KB	Share
OCC Change in substantial holding MC
19/01/18		46.86KB	Share
OCC Change in substantial holding QXZ
19/01/18		134.34KB	Share
OCC New Patent for Suture-Less Repair of Soft Tissue Secured
18/01/18	PRICE SENSITIVE	202.42KB	Share
OCC Successful Completion of Share Purchase Plan
12/01/18		142.64KB	Share
OCC Appendix 3B
12/01/18		152.97KB	Share
OCC Orthocell featured at Biotech Showcase in San Francisco
09/01/18		1.73MB	Share
OCC 50% Patient Treatment Milestone in Human Nerve Trial
02/01/18	PRICE SENSITIVE	198.74KB	Share
OCC Share Purchase Plan Closing Date Extended
28/12/17		111.04KB	Share
OCC Appendix 3B and Notice Under Section 708A
20/12/17		157.61KB	Share
OCC Invitation to Participate in Share Purchase Plan
15/12/17		201.69KB	Share
OCC Notice Under ASIC Class Order CO 09/425
15/12/17		111.07KB	Share
OCC Orthocell Granted European Tendon Regeneration Patent
15/12/17	PRICE SENSITIVE	142.65KB	Share
OCC Orthocell Featured in CommSec Executive Series Interview
14/12/17		387.54KB	Share
OCC Placement and Share Purchase Plan
13/12/17	PRICE SENSITIVE	568.26KB	Share
OCC Trading Halt
11/12/17	PRICE SENSITIVE	356.15KB	Share
OCC Ortho-ATI Case Study Publication
08/12/17	PRICE SENSITIVE	145.58KB	Share
OCC Orthocell Commences Treatment of its 1,000th Patient
07/12/17		164.85KB	Share
OCC Orthocell Granted European Cartilage Regeneration Patent
01/12/17	PRICE SENSITIVE	117.55KB	Share
OCC *Change of Director's Interest Notice - options expiry 5**
30/11/17		395.15KB	Share
OCC FDA Comprehensive Regenerative Medicine Policy Framework
27/11/17		163.71KB	Share
OCC Company Update Presentation
21/11/17		2MB	Share
OCC Results of Meeting
15/11/17		105.8KB	Share
OCC Orthocell Receives CE Mark for CelGro
09/11/17	PRICE SENSITIVE	214.17KB	Share
OCC Trading Halt
08/11/17	PRICE SENSITIVE	337.57KB	Share
OCC Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	157.57KB	Share
OCC Orthocell receives R&D tax incentive refund
24/10/17	PRICE SENSITIVE	126.1KB	Share
OCC Company Update Presentation
17/10/17		2.05MB	Share
OCC Orthocell Granted CelGro Patent Protection in Canada
16/10/17	PRICE SENSITIVE	111.48KB	Share
OCC Notice of Annual General Meeting/Proxy Form
13/10/17	PRICE SENSITIVE	1.01MB	Share
OCC Surgical Specialties Appointed as Exclusive Distributor
11/10/17	PRICE SENSITIVE	111.15KB	Share
OCC Orthocell Receives New Patent for Celgro Platform Technology
21/09/17	PRICE SENSITIVE	137.56KB	Share
OCC Appendix 4G
14/09/17		209.39KB	Share
OCC Annual Report to shareholders
14/09/17		5.77MB	Share
OCC Celgro Positive Safety and Performance in Human Hip Study
06/09/17	PRICE SENSITIVE	110.52KB	Share
OCC 1st Patient Recruited in Ortho-ATI Shoulder Tendon Study
05/09/17	PRICE SENSITIVE	270.38KB	Share
OCC Preliminary Final Report
31/08/17	PRICE SENSITIVE	141.37KB	Share
OCC Change of Director's Interest Notice SW
08/08/17		28.46KB	Share
OCC Change of Director's Interest Notice PA
08/08/17		26.97KB	Share
OCC Change of Director's Interest Notice MC
08/08/17		26.67KB	Share
OCC Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	152.98KB	Share
OCC Change of Director's Interest Notice PA
25/07/17		27.74KB	Share
OCC Change of Director's Interest Notice MC
24/07/17		28.2KB	Share
OCC Change of Director's Interest Notice SW
24/07/17		28.04KB	Share
OCC Appendix 3B
20/06/17		153.27KB	Share
OCC Ortho-ACI on Australian Register of Therapeutic Goods
30/05/17	PRICE SENSITIVE	393.81KB	Share
OCC Ethics Approval Received for Pilot Ortho-ATI Tendon Study
01/05/17	PRICE SENSITIVE	395.89KB	Share
OCC Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	198.16KB	Share
OCC Response to ASX Query
11/04/17	PRICE SENSITIVE	292.39KB	Share
OCC Response to ASX Price and Volume Query
10/04/17		292.96KB	Share
OCC Singapore Patent for CelGro SMART Graft Received
28/03/17	PRICE SENSITIVE	399.32KB	Share
OCC Appendix 3B
22/03/17		806.38KB	Share
OCC Half Yearly Report and Accounts
28/02/17	PRICE SENSITIVE	692KB	Share
OCC Orthocell Announces Gluteal Tendon Publication
27/02/17	PRICE SENSITIVE	392.76KB	Share
OCC Investor Presentation Hong Kong
27/02/17		3.81MB	Share
OCC Initial Results Positive for CelGro Human Nerve Regeneration
22/02/17	PRICE SENSITIVE	397.25KB	Share
OCC Orthocell Submits US Regulatory Application for CelGro
08/02/17		400.65KB	Share
OCC Orthocell Submits US Regulatory Application for CelGro
08/02/17	PRICE SENSITIVE	401.15KB	Share
OCC Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	147.09KB	Share
OCC Orthocell Cell Factory Patent Granted in Europe
31/01/17	PRICE SENSITIVE	401.51KB	Share
OCC Orthocell Announces Collaboration with Johnson & Johnson
12/01/17	PRICE SENSITIVE	384.02KB	Share
OCC Trading Halt
11/01/17	PRICE SENSITIVE	409.26KB	Share
OCC Orthocell receives R&D tax incentive refund
09/01/17	PRICE SENSITIVE	122.97KB	Share
OCC Ceasing to be a substantial holder
16/12/16		109.27KB	Share
OCC Ceasing to be a substantial holder
15/12/16		108.16KB	Share
OCC Placement Completed
13/12/16		385.51KB	Share
OCC Appendix 3B
13/12/16		823.48KB	Share
OCC Change of Share Registry Address
09/12/16		208.53KB	Share
OCC Orthocell Announces $4 million Capital Raising
07/12/16	PRICE SENSITIVE	391.36KB	Share
OCC Trading Halt
02/12/16	PRICE SENSITIVE	190.09KB	Share
OCC Change of Director's Interest Notice PA
02/12/16		307.48KB	Share
OCC Investor Presentation
02/12/16		1.6MB	Share
OCC Appendix 3B
28/11/16		123.96KB	Share
OCC Results of Meeting
28/11/16		381.58KB	Share
OCC Appendix 4C - quarterly-OCC.AX
31/10/16	PRICE SENSITIVE	290.26KB	Share
OCC WA Innovation Excellence Award for CelGro Received-OCC.AX
31/10/16		282.46KB	Share
OCC Orthocell Announces Growth Factor - Cell factory Publication-OCC.AX
31/10/16	PRICE SENSITIVE	280.7KB	Share
OCC Appendix 4G-OCC.AX
26/10/16		217.93KB	Share
OCC Annual Report to shareholders-OCC.AX
26/10/16		5.07MB	Share
OCC Notice of Annual General Meeting/Proxy Form-OCC.AX
26/10/16		1.44MB	Share
OCC Approval for CelGro Human Nerve Regeneration Study Received-OCC.AX
18/10/16	PRICE SENSITIVE	281.96KB	Share
OCC Appendix 3B-OCC.AX
14/10/16		804KB	Share
OCC Investor Presentation CelGro-OCC.AX
19/09/16		12.02MB	Share
OCC Research Report-OCC.AX
14/09/16		366.87KB	Share
OCC Full Year Statutory Accounts-OCC.AX
12/09/16		1.19MB	Share
OCC Amended Change of Director's Interest Notice MC-OCC.AX
12/09/16		311.69KB	Share
OCC Preliminary Final Report-OCC.AX
31/08/16	PRICE SENSITIVE	533.05KB	Share
OCC Release of Securities from Escrow-OCC.AX
02/08/16		213.15KB	Share
OCC Appendix 4C - quarterly-OCC.AX
29/07/16	PRICE SENSITIVE	597.03KB	Share
OCC Ethics Approval for Pivotal Ortho ATI Tendon Study Received-OCC.AX
12/07/16	PRICE SENSITIVE	383.16KB	Share
OCC Change of Director's Interest Notice SW-OCC.AX
01/07/16		225.08KB	Share
OCC United States Tendon Stem Cell and Scaffold Patent Obtained-OCC.AX
21/06/16	PRICE SENSITIVE	383.31KB	Share
OCC Chinese Patent Received Covering Celgro SMART Graft-OCC.AX
17/06/16	PRICE SENSITIVE	226.76KB	Share
OCC Early Positive Results for CelGro in Human Tendon Study-OCC.AX
16/06/16	PRICE SENSITIVE	373.13KB	Share
OCC Orthocell Receives Approval for Human Hip Study Using Celgro-OCC.AX
04/05/16	PRICE SENSITIVE	385.63KB	Share
OCC Orthocell receives R&D tax incentive refund-OCC.AX
02/05/16	PRICE SENSITIVE	376.67KB	Share
OCC Appendix 4C - quarterly-OCC.AX
29/04/16	PRICE SENSITIVE	167.82KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.23		Change 0.005(0.41%)		Mkt cap ! $301.1M

Open	High	Low	Value	Volume
$1.23	$1.23	$1.19	$314.5K	259.6K

Buyers (Bids)

No.	Vol.	Price($)
2	20994	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.23	38124	3

View Market Depth

No.	Vol.	Price($)
2	20994	1.205
1	30000	1.200
2	20990	1.195
9	34522	1.190
1	843	1.185

Price($)	Vol.	No.
1.230	38124	3
1.240	30350	3
1.245	30287	2
1.250	86601	3
1.260	3550	1

Last trade - 16.10pm 12/08/2025 (20 minute delay)


Last $1.22		Change 0.005 ( 0.13 %)
Open	High	Low	Volume
$1.22	$1.23	$1.19	114626
Last updated 15.59pm 12/08/2025 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories